STDs and dermatologic symptoms

News
Article

Kenneth J. Tomecki, MD, discussed the clinical relevance of sexually transmitted diseases to dermatology and outlined what to look for and how to treat various conditions at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

Sexually transmitted diseases and infections (STDs/STIs) are common health issues in the United States, according to Kenneth J. Tomecki, MD, staff physician in the department of dermatology at the Cleveland Clinic, and past president of the American Academy of Dermatology.1 He cited 2018 data from the Centers for Disease Control and Prevention (CDC) that revealed 1 in 5 people in the United States had an STI. In that year alone, there were 26 million newly acquired STIs, nearly 50% of which were acquired by people aged 15 to 24 years. Nearly $16 billion was spent on direct medial costs.2

In light of these statistics, it is important that physicians expand their knowledge about different STDs and how to treat them, Tomecki said.

Tomecki ended his presentation with key facts about the STDs/STIs in 20223:

  • There are 1 million STIs acquired every day worldwide, with most patients being asymptomatic,
  • Each year there are an estimated 374 million new infections, with one fourth of STIs being chlamydia, gonorrhea, syphilis, and trichomoniasis,
  • More than 500 million people 15 to 50 years old are estimated to have genital HSV infection and up to 1 million pregnant women had syphilis as of 2018,
  • There are as many as 350,00 adverse outcomes
  • The drug resistance of these diseases is increasing, notably in gonorrhea

Originally published on our sister brand, Dermatology Times.

Disclosure:

Tomecki reported no relevant disclosures.

References:

  1. Tomecki, K.STDs: the dirty half dozen. Presented at: 2022 Fall Clinical Dermatology Conference for PAs & NPs; June 3-5, 2022 Scottsdale, AZ and virtual.
  2. CDC newsroom. CDC. Published January 25, 2021. Accessed June 3, 2022. https://www.cdc.gov/media/releases/2021/p0125-sexualy-transmitted-infection.html
  3. Sexually transmitted infections (STIs). Accessed June 3, 2022. https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis)

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Related Content
© 2025 MJH Life Sciences

All rights reserved.